SHOW DIRECTORY
Invest Like the Best
Deep conversations with investors, founders, and operators about business quality, capital allocation, strategy, and enduring competitive advantage.
BIDCLUB DESCRIPTION
The Flaw Behind Everything Wrong With US Healthcare
Patrick O'ShaughnessyZach Reitano
Healthcare spending can grow if it buys more healthy years, but Reitano argues America’s core flaw is that “the patient is not the client.”Ro’s cash-pay GLP-1 model can lower prices and increase drugmaker profits through volume, while investment in records, labs, pharmacies, and clinical networks helped it scale demand.After a reset, Ro grew annual revenue from approximately $250 million to more than $3 billion over four years; broader GLP-1 adoption still depends on access, tolerability, and continued innovation.
